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Long-Lasting T Cell-Independent IgG Responses Require MyD88-
Mediated Pathways and Are Maintained by High Levels of Virus
Persistence
Forum M. Raval,a Rabinarayan Mishra,a Robert L. Garcea,b Raymond M. Welsh,a Eva Szomolanyi-Tsudaa
Department of Pathology and Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, Massachusetts, USAa; Department of
Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado, USAb
ABSTRACT Many viruses induce acute T cell-independent (TI) B cell responses due to their repetitive epitopes and the induction
of innate cytokines. Nevertheless, T cell help is thought necessary for the development of long-lasting antiviral antibody re-
sponses in the form of long-lived plasma cells andmemory B cells. We found that T cell-deficient (T cell receptor  and  chain
[TCR] knockout [KO]) mice persistently infected with polyomavirus (PyV) had long-lasting antiviral serum IgG, and we
questioned whether they could generate TI B cell memory. TCRKOmice did not form germinal centers after PyV infection,
lacked long-lived IgG-secreting plasma cells in bone marrow, and did not have detectable memory B cell responses. Mice defi-
cient in CD4 T cells had a lower persisting virus load than TCRKOmice, and these mice had short-lived antiviral IgG re-
sponses, suggesting that a high virus load is required to activate naive B cells continuously, andmaintain the long-lasting serum
IgG levels. Developing B cells in bone marrow encounter high levels of viral antigens, which can cross-link both their B cell re-
ceptor (BCR) and Toll-like receptors (TLRs), and this dual engagement may lead to a loss of their tolerance. Consistent with this
hypothesis, antiviral serum IgG levels were greatly diminished in TCRKO/MyD88/mice. We conclude that high persisting
antigen levels and innate signaling can lead to the maintenance of long-lasting IgG responses even in the absence of T cell help.
IMPORTANCE Lifelong control of persistent virus infections is essential for host survival. Several members of the polyomavirus
family are prevalent in humans, persisting at low levels in most people without clinical manifestations, but causing rare morbidi-
ty/mortality in the severely immune compromised. Studying the multiple mechanisms that control viral persistence in a mouse
model, we previously found that murine polyomavirus (PyV) induces protective T cell-independent (TI) antiviral IgG. TI anti-
body (Ab) responses are usually short-lived, but T cell-deficient PyV-infected mice can live for manymonths. This study investi-
gates how protective IgG is maintained under these circumstances and shows that these mice lack both forms of B cell memory,
but they still have sustained antiviral IgG responses if they have high levels of persisting virus and intact MyD88-mediated path-
ways. These requirements may ensure life-saving protection against pathogens even in the absence of T cells, but they prevent
the continuous generation of TI IgG against harmless antigens.
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Serological memory, the long-term maintenance of virus-specific antibody (Ab) in serum, plays an important role in the
control of persistent infections by inhibiting viral recrudescence.
Two types of long-lived antigen (Ag)-specific B cell populations
are responsible for the sustained serum Ab levels: the long-lived
plasma cells (LL PCs) and memory B cells (BMEM). LL PCs are
terminally differentiated cells fully committed to the secretion of
Abs; they reside in the bone marrow where they receive survival
signals continuously. BMEM cells, on the other hand, do not secrete
immunoglobulins (Ig), but they are Ag-experienced cells that can
rapidly secrete large amounts of Ab upon restimulation. Both of
these long-lived B cell populations are derived from germinal cen-
ters (GC) and thought to be dependent on T cell help (1). Ab
responses can also be generated without T cell help, and these T
cell-independent (TI) Ab responses are usually short-lived (2).
The typical TI Ags, such as 4-hydroxy-3-nitrophenylacetyl (NP)-
Ficoll or bacterial polysaccharides, are not proteins, and thus can-
not be presented by Ag-presenting cells (APCs) as peptides to
activate helper CD4 T cells. Therefore, these TI Ags usually do
not induce GC formation and subsequent LL PC and recall BMEM
generation.
Polyomavirus (PyV) is a small double-stranded DNA virus
that causes a lifelong low-level persistent infection in mice (3).
This virus is well controlled and does not cause disease in immu-
nocompetent animals but leads to tumor development aftermany
months in T cell-deficient mice (3, 4). Previously we found that
PyV infection can induce a potent TI IgG response in T cell-
deficient mice. These TI Ab responses are protective (5); they re-
duce the viral load and prevent virus-induced lethal acute my-
eloproliferative disease, observed in PyV-infected T and B cell-
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deficient SCID mice (6). TI IgG responses to PyV are mostly
specific for the major capsid protein, VP1, and are predominantly
of the IgG2a/c and IgG2b isotypes (7). This response is in contrast
to the TI Ab responses induced by typical TI polysaccharide Ags,
which are mainly IgM and IgG3 (8, 9). Testing the capacity of
various forms of viral Ags (live PyV, VP1 protein, or virus-like
particles) to induce TI Ab responses, we found that TI IgG is
induced only if T cell-deficient mice are infected with live PyV
(10). This observation suggests an important role for innate and
inflammatory signals induced by the live, replicating virus in the
generation of TI IgG specific to this infection (11).
T cell receptor  chain (TCR) knockout (KO) mice, which
lackT cells, andTCRKOmice, which lack bothTand
T cells, survive PyV infection formanymonths butmaintain ~10-
fold-higher persisting virus loads than wild-type C57BL/6 (B6)
mice (4). Although the level of PyV persistence is not different in
TCR KO and TCR KOmice, these mice differ greatly in their
tumor susceptibility. Whereas most TCR KO mice develop
PyV-induced salivary gland tumors between 5 and 8 months
postinfection, TCR KO mice live well beyond this time without
apparent pathology (4, 5). The relatively long life span of PyV-
infected T cell-deficient mice, which have only B cell-derived
adaptive immune responses, suggests that the TI IgG responses
may be long-lived, because mice which lack both T and B cells die
rapidly after infection.
In the studies reported here, we have investigated the longevity
of antiviral IgG responses in PyV-infected T cell-deficient mice.
We also questioned how PyV-specific IgG responses are main-
tained in the absence of T cells and whether innate immune path-
ways are involved in the generation and maintenance of TI anti-
viral IgG. Here, we provide evidence that PyV-infected T cell-
deficient mice have long-lasting antiviral serum IgG responses,
but the longevity of these responses is not due to the presence of LL
PC in the bonemarrow or BMEM. Instead, the TI IgG is likely to be
continuously generated by short-lived B cells and requires high
persisting virus load and intact MyD88-mediated innate immune
pathways.
RESULTS
Sustained antiviral IgG responses in the sera of PyV-infected T
cell-deficient mice. To test the longevity of T cell-independent
(TI) Ab responses, antiviral serum IgG levels of TCR KO mice
and control immunocompetent C57BL/6 (B6) mice were mea-
sured at various time points after PyV infection. At 3 months
postinfection, TCR KOmice maintained VP1-specific IgG lev-
els in serum, similar to wild-type B6 mice (Fig. 1). Pooled serum
samples taken from TCR KOmice sequentially at various time
points in an independent experiment also showed the mainte-
nance of virus-specific IgG responses up until 6 months postin-
fection, the latest time point tested. The VP1-specific IgG end-
point titerswere approximately 50-fold higher in pooled sera from
B6 mice (1.6 106) compared to TCR KOmice (3.2 104) at
5 months postinfection, and these data on the magnitude of TI
IgG responses were consistent with published experiments from
our laboratory (10).
Lack of GC B cells, bone marrow PCs, and recall memory B
cell responses in T cell-deficient mice. Long-lived Ab responses
are usually derived from long-lived plasma cells (LL PCs) and
from the activation of memory B cells (BMEM), and both of these
cell types are normally generated from T cell-dependent (TD)
germinal center (GC) responses. However, there are reports of TI
GC formation (12, 13). Moreover, PyV (and other TI viral Ags)
differ from the prototypical polysaccharide TI Ags, as they are
proteins and inducemostly TI IgG2a/c, not IgM and IgG3. There-
fore, we tested whether T cell-deficient mice form GC upon PyV
infection. Splenocytes harvested from TCR KOmice and wild-
type controls 8 days after intraperitoneal (i.p.) PyV infection were
examined by flow cytometry for GC B cells. The splenocytes were
gated on CD19 B220 cells and GL-7 and Fashigh were consid-
ered GC B cells. The level of GC B cells in the spleens of B6 mice
increased from 0.11% in uninfected mice (background) to 2.05%
by day 8. TCRKOmice, however, did not haveGCB cells above
the frequencies in naive controls (Fig. 2). These data show that T
cell-deficient mice are not able to generate GC B cells in response
to PyV infection and are consistent with our previously published
findings showing that the spleens of PyV-infected TCRKOmice
lacked peanut agglutinin (PNA)-stainingGC visualized by immu-
nohistochemistry (10).
PyV has been characterized as a TI type II Ag, as it fails to
induce antibody responses in T cell-deficient Xid mice, which
have B cells with Btk kinase mutation (14). It has been reported
that some TI type II Ags can generate memory B cell responses.
Hence, we tested whether the presence of long-lasting antiviral
serum IgG in PyV-infectedT cell-deficientmicewas due to LLPCs
in bone marrow and/or BMEM cells. TCR KO mice and wild-
type B6 controls were infected with PyV, and at various time
points, their spleens and bone marrow were tested for VP1-
specific antibody-secreting cells (ASCs) by enzyme-linked immu-
nosorbent spot (ELISPOT) assays. Wild-type mice, as shown in
Fig. 3, had IgG-producing ASC frequencies of 40 to 140 per 106
spleen cells at all three time points after infection. Similarly, T
cell-deficient mice had VP1-specific ASCs in their spleens at all
three time points, and over time the frequency of ASCs increased.
ASCs in bone marrow represent LL PCs that usually appear a few
weeks postinfection (15). At 6 weeks postinfection, virus-specific
ASC frequencies in bone marrow were readily detected in wild-
type mice (frequencies of ~40/106 bone marrow cells), and their
frequency increased by 6 months. In contrast, we did not observe
ASCs in the bone marrow of T cell-deficient mice 6 months
postinfection (Fig. 3A), suggesting that T cell-deficient mice are
not able to generate IgG-secreting LL PCs.
FIG 1 Serum IgG responses to PyV infection are long-lived in TCR KO
mice. VP1-specific IgG in sera of TCRKOmice (n 5) and B6mice (n 2)
3 months postinfection is compared to pooled sera of uninfected B6 mice.
Mean values of absorbance (optical density at 450 nm [o.d. 450]) standard
deviations (SD) (error bars) are shown at various serum dilutions. The results
of one of three experiments are shown. WTB6, wild-type B6.
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BMEM cells that can be reactivated also contribute to long-term
humoral immunity. Studying BMEM in mice is a difficult task,
because there is no surface marker available that can unambigu-
ously identify murine BMEM (16, 17). Therefore, we have devel-
oped and utilized a functional adoptive transfer assay in order to
study murine BMEM IgG responses. This assay was based on dem-
onstrating early (day 5 to 7) recall IgG responses to PyV. Spleen
cells from PyV-immune B6 mice (groups 1 and 2) or naive mice
FIG 2 PyV-infected TCR KOmice are defective in GC B cell formation. The spleens of naive and PyV-infected TCR KO and B6 mice on day 8 (d8) after
infection were examined by flow cytometry. The fluorescence-activated cell sorting (FACS) plots were gated on B220 CD19 B cells; the box gates indicate
Fashigh/GL7 GC B cells. WT, wild type.
FIG3 TCRKOmice lack bonemarrowPC and BMEM after PyV infection. (A) TCRKOandB6mice were examined for VP1-specific IgGAb-secreting cells
(ASC) in their spleen and bone marrow at 3 weeks, 6 weeks, and 6 months after PyV infection. Mean values SD are shown. The figure shows the results of a
representative experiment (three experiments were performed). (B) VP1-specific serum IgG ELISAs of SCID mice reconstituted with PyV-immune (groups 1
and 2) or naive (groups 3 and 4) spleen cells from wild-type B6 (WTB6), TCR KO (white bars), TCR KO (checkered bars) or TCR KO (striped bars) mice.
SCID mice in group 1 reconstituted with PyV-immune splenocytes were infected with PyV 1 day after cell transfer, and mice in group 2 were left uninfected.
Similarly, mice in group 3 that received naive cells were infected with PyV, and mice in group 4 were left uninfected. The ELISA was done on serum samples
collected 7 days postinfection at a serum dilution of 1:200. The results of a representative experiment are shown (three experiments were performed).
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(groups 3 and 4) were transferred into naive SCID mice, which
were infected with PyV (groups 1 and 3) ormock infected (groups
2 and 4) on the next day. Mice that received nonimmune spleen
cells and were infected with PyV (group3), or mice that received
PyV-immune splenocytes but were not infected with PyV (group
2), as well as mice which received nonimmune splenocytes and
were left uninfected (group 4), had very low or undetectable VP1-
specific IgG in their sera at this early time point. SCIDmice which
received PyV-immune spleen cells and PyV infection (group 1),
however, had measurable antiviral IgG responses by days 5 to 7
postinfection. To test whether T cell-deficient mice are capable of
having IgG recall responses, these functional memory B cell assays
were performed with spleen cells of PyV-immune and naive
TCR KO, TCR KO, and TCR KOmice along with wild-type
B6 mice. SCID mice given virus-immune wild-type B6 or TCR
KO spleen cells and secondary PyV infection were able to generate
good recall (BMEM) responses to PyV. On the other hand, SCID
mice reconstituted with virus-immune TCR KO or TCR KO
spleen cells along with a PyV infection were unable to generate
BMEM responses (Fig. 3B). These data demonstrated that BMEM
recall responses depend on  T cells. Our findings therefore in-
dicated that the long-lasting serum IgG responses in T cell-
deficient mice are not due to the presence of LL PCs or BMEM.
The persisting viral load is higher in T cell-deficient mice
than in wild-type mice. CD4 T cell-deficient mice (I-Ab/)
infected with PyV generated short-term Ab responses to PyV and,
similar to TCR KO mice, lacked LL PCs in bone marrow (18).
On day 8 postinfection, VP1-specific IgG levels were similar in
wild-type B6 and I-Ab/mice, but by 23 days postinfection, they
decreased in I-Ab/mice compared to wild-type B6mice, and by
day 86, they were almost undetectable. These data demonstrated
that TI Ab responses are not maintained in mice that lack only
CD4 T cells (18). In contrast, mice that lack both CD8 and
CD4 T cells maintain TI antiviral serum IgG responses. PyV
causes a persistent infection, and CD8 T cells are known to ef-
fectively control the PyV load (19, 20). We reasoned that an ele-
vated virus load in mice that lack all  T cells, including CD8
cytotoxic T lymphocytes (CTL), compared tomajor histocompat-
ibility complex (MHC) class II-deficient mice (I-Ab), which have
normal CTL responses to PyV, may play a role in maintaining
long-lived Ab responses in T cell-deficient mice. PyV levels in the
kidney, lung, and spleen of TCR KO mice and wild-type B6
controls were determined on day 14 following PyV infection. In-
deed, TCRKOmice had 10-fold-higher levels of PyV thanwild-
type mice did (Fig. 4A and B), whether the mice were infected i.p.
or intranasally (i.n.). Thus, the elevated virus load in TCR KO
mice, compared to B6mice,may contribute to themaintenance of
long-lasting TI Ab responses in these mice.
Decrease in virus load after transfer of CD8 T cells into
TCR KO mice is associated with rapidly declining antiviral
serum IgG levels.Wequestionedwhether high levels of persistent
PyV are responsible for the long-lasting Ab responses in T cell-
deficient mice. Naive CD8 T cells, obtained by magnetic cell
separation (MACS) enrichment, from the spleens of uninfected
B6micewere transferred into TCRKOmice. The following day
(day 1), the CD8 T cell-reconstituted TCR KO mice were
FIG 4 Higher levels of PyV persistence are seen in the organs of T cell-deficient mice compared to B6mice. (A and B) PyV load in the organs of TCRKO and
wild-type B6 mice 14 days after intraperitoneal (A) or intranasal (B) infection. Each symbol represents the value for an individual mouse. The mean values
(horizontal bar) SD (error bar) for the groups are indicated. Values that are statistically significantly different are indicated by horizontal bars and P values. (C)
PyV load in the bone marrow of B6 and TCR KO mice 3 months after i.p. infection (n 3).
Raval et al.

















infected with PyV, as was a control group of T cell-deficient mice
that received no cell transfer. Serum samples were collected, and
PyV-specific IgG levels were determined at 1, 3, 5, and 7 weeks
postinfection (Fig. 5a). At 1 week postinfection, the VP1-specific
IgG responses were similar in the two groups.However, over time,
TCR KO mice that had received CD8 T cells generated lower
levels of virus-specific IgG. PyV viral loads were also measured at
the last time point of the study (7 weeks postinfection) and were
~3 orders of magnitude higher in the spleens of TCR KOmice
without cell transfer than in mice that received CD8 T cells (Fig.
5b). This experiment established a correlation between the pres-
ence of CD8 T cells, lower persisting virus load, and lower Ab
responses.
Diminished antiviral IgG responses in T cell-deficient
MyD88 KO mice. On the basis of the results described above, we
hypothesized that a high level of persistent PyV antigen in TCR
KO mice may activate naive B cell populations that continuously
emerge from the bone marrow, thereby maintaining the long-
lasting IgG responses in T cell-deficient mice. This mechanism
raises the question of whether B cells encounter PyV during their
development in the bone marrow, and if so, how can they bypass
tolerance? We first tested whether PyV was present in the bone
marrow of TCRKOmice. TCRKOmice and wild-type con-
trols were infected with PyV, and 3 to 4 months postinfection, we
harvested bone marrow cells from these mice and performed
quantitative PCR (qPCR) to determine the numbers of PyV ge-
nome copies in these samples. Bone marrow cells from TCR
KOmice harbored high levels of PyV, indicating that viral Ag was
present at the site of B cell development (Fig. 4C).
The high virus load in bone marrow suggested that B cells that
were developing there encountered PyV, but this encounter may
not lead to tolerance, as newly emerging mature B cells seemed to
continue to generate Ab to PyV in the periphery. A report by
Berland et al. (21) suggested that “dual specificity” antigens, which
ligate the B cell receptor (BCR) and endosomal Toll-like receptors
(TLRs) such as TLR7/8 and TLR9 may break B cell tolerance. In
that study, B cells with a transgenic BCR specific for the autoanti-
gens RNA, double-stranded DNA (dsDNA), and nucleosomes,
showed a TLR7-dependent loss of B cell tolerance. PyV can also be
considered an antigen capable of “dual engagement” of BCR and
innate receptors, as we have found that PyV infection activates
MyD88-mediated pathways initiated by TLRs (22; F. M. Raval,
unpublished data), and PyV antigens also engage the BCR of some
B cells. Therefore, we hypothesized that TCR KO mice, with
high levels of PyV in bonemarrow,may lose their tolerance to PyV
and that this disruption of tolerancemay beMyD88 dependent. In
this case, it would follow that in T cell-deficient MyD88 KOmice,
tolerance would be developed, and new B cells emerging from the
bone marrow would not respond to persisting PyV, leading to
diminished antiviral serum IgG. To seewhetherMyD88-mediated
pathways are needed for continuous generation of TI IgG, we
infected TCR MyD88 triple-knockout mice (TCR KO/
MyD88/) and mice that are T cell deficient but MyD88/
(TCRKO) with PyV. VP1-specific IgG responses were tested at
1, 2, and 4 weeks after PyV infection (Fig. 6). The virus-specific
IgG levels were similar in TCR KO/MyD88/ mice and
TCRKOmice at 1 week postinfection, but the IgG responses to
PyV were significantly lower in TCR KO/MyD88/mice at 2
and 4 weeks postinfection (~40-fold lower on week 2 and ~100-
fold lower on week 4). TCR KO/MyD88/mice generated on
average slightly higher but not statistically significantly different
levels of VP1-specific IgM (Fig. 6). These results suggest that
MyD88 signaling is required to generate high levels of sustained
PyV-specific IgG responses in T cell-deficientmice. It is important
to note that onweek 6 postinfection, the virus loads in TCRKO
and TCR KO/MyD88/mice were not significantly different
(data not shown).
FIG 5 Reduced levels of PyV persistence are associated with rapidly decreasing serum IgG titers. (a) TCR KO mice that received CD8 T cells (black bars)
or no cell transfer (white bars) were tested for their VP1-specific serum IgG at various time points postinfection. The endpoint titers of groups of mice (5 mice
in each group) are shown. (b) PyV load of TCR KOmice which were reconstituted with CD8 T cells 1 day prior to infection or left alone (no cell transfer).
The number of PyV genome copies per microgram of DNA from spleen tissue at 7 weeks postinfection is shown.
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In this study, we show that mice have long-lasting serological
memory after PyV infection and that high levels of virus-specific
serum IgG are maintained even in the absence of T cells. This is
achievedwithout the formation ofGC, LL PCs in bonemarrow, or
BMEM. The maintenance of this “TI serological memory,” how-
ever, requires high virus load and intact MyD88-mediated path-
ways in the host. PyV is a TI Ag, which differs in many ways from
some well-characterized and frequently used TI Ags such as bac-
terial polysaccharides, 4-hydroxy-3-nitrophenylacetyl (NP)-
lipopolysaccharide (LPS) orNP-Ficoll. The chemical nature of the
viral capsid is protein, not polysaccharide. Moreover, PyV is not
inert, but a live, replicating virus that can elicit innate, inflamma-
tory, or danger signals. Therefore, it was of interest to systemati-
cally investigate the mechanisms that allow the maintenance of
potentially life-saving long-term IgG levels in virus-infected
TCR KO mice.
The formation of GC is a prerequisite for BMEM and long-lived
PC formation in TD responses. GC are normally not generated in
the absence of T cells, but under unusual circumstances, such as in
BCR transgenic mice with a high frequency of high-affinity
antigen-specific B cells, or after immunization with very high
doses of TI Ags (NP-Ficoll), short-lived GC, defined by clusters of
PNA-positive and GL-7-positive B cells, can be induced in a TI
manner (12, 13). These TI GC, however, do not appear to be
functional, as no somatic hypermutation was detected in the TI
GC B cells (12), and these GC did not persist past day 5 following
immunization. In this study, we showed that TCR KO mice
infected with PyV did not show an increase in GC B cell frequen-
cies in the spleen above background levels on day 7 and later.
Therefore, the long-lasting TI serum IgG responses to PyV are not
products of an unusual, pathogen-induced TI GC reaction.
The nonsecreting form of B cell memory resides in antigen-
experienced quiescent BMEM, which can be rapidly activated in
recall responses, giving faster and more robust responses to re-
challenge than naive B cells. BMEM are usually formed in TD re-
sponses, but there are some reports of TI BMEM. One of the most
cited examples of “TI B cell memory” is a report by Alugupalli et
al. (8). This report showed that TI IgM generated by B1b cells is
crucial for the clearance of Borrelia hermsii, a pathogen causing
relapsing fever in mice. Moreover, the B1b cell population that
expands during B. hermsii infection can survive for months in a
pathogen-free host and provides a long-lasting protective effect, as
it can respond to Borreliawith IgM secretion. The “TI B cell mem-
ory” in this case is not manifested by continuously secreting LL
PCs or by BMEM giving fast IgG recall responses. Instead, the
heightened humoral immunity is due to the increased number of
B1b cells that are in a nonsecreting silent state but are capable of
secreting IgM again if they are stimulated (8).
Immunization with the TI type II Ag, NP-Ficoll, can also lead
to B cell responses that persist for months. These IgM and IgG3
responses are generated by extrafollicular B1b plasmablasts, not
by the conventional memory B cell populations (23).Whether the
relative longevity of the extrafollicular B1b cells compared to ex-
FIG 6 Antiviral serum IgG is diminished in T cell-deficient MyD88/ mice. (a) VP1-specific serum IgG titers of TCR KO (MyD88/) and TCR
KO/MyD88/mice 1, 2, and 4 weeks postinfection shown (on a log scale).*, IgG titers equal or larger than 105. (b) VP1-specific serum IgM titers of the same
mice 4 weeks postinfection (note that the y axis is linear).
Raval et al.

















trafollicular B2 TD plasmablasts is due to self-renewal of the
antigen-activated B1b cells or to other mechanisms has not been
elucidated. Relatively long-lived bone marrow PC responses to
NP-LPS were reported recently, but these were unswitched IgM-
secreting PCs (24).
Using the definition of Ag-experienced resting, nonsecreting B
cells for BMEM, Obukhanych et al. (9) reported the formation of
suchmemory B cells, some of which were isotype switched to IgG,
in response to the TI Ag NP-Ficoll. The B cells in this study were
labeled with a bromodeoxyuridine (BrdU) pulse when they were
dividing upon the first encounter with the Ag, so that the antigen-
experienced cells could be distinguished from the naive B cells.
The TI BMEM described in this report, however, were fundamen-
tally different from the “conventional” BMEM that usually form in
a TD response, because they did not give an enhanced “recall” IgG
response to secondary challenge (9).
In our studies, we tested whether the spleen cells of PyV-
immune T cell-deficient mice can mount a fast and enhanced
recall IgG response to PyV rechallenge in a functional adoptive
transfer assay. Using this assay, we found that recall IgG responses
were given only by the splenic B cells of PyV-immune mice that
had  T cells, such as B6 and TCR KO mice, but not by TCR
KO or TCR KO mice. Therefore,  T cell help is essential for
the formation of recall BMEM even when immunized with PyV, an
infectious viral TI Ag.
LL PCs can maintain serological memory even in the absence
of any other B cells, as shown by experiments using depletions of B
cells with Ab to CD20 (25). The CD20-specific depleting Ab elim-
inates both naive B cells and BMEM but spares fully differentiated
PCs. We found that mice without T cell help, including both the
CD4 T cell-defective I-Ab/ mice (18) and the  T cell-
defective TCR KO or TCR KO mice, could not accumulate
IgG-secreting PCs in their bone marrow, the site of LL PC accu-
mulation following acute virus infections (15). Therefore, LL PCs
could not be responsible for themaintenance of TI antiviral serum
IgG.
This report demonstrates the existence of high antiviral serum
IgG for as long as 6 months after infection (the length of our
study) in TCR KO and TCR KO mice. Previously we had
observed that the TI IgG responses to PyV in I-Ab/ mice were
short-lived and that they greatly decreased after day 23 postinfec-
tion (18). How could we reconcile these results that seem to be
contradictory? A major difference between PyV-infected I-Ab/
and TCR KO or TCR KO mice is the amount of persisting
virus they harbor. Consistent with the antiviral role of CD8 T
cells, I-Ab/mice, which have CD8 cytotoxic T cell responses,
have a low level of PyV persistence that is undistinguishable from
that of B6mice. On the other hand, TCRKOor TCRKOmice
lack CD8 T cell responses and have a10-fold-higher persisting
PyV load compared to that of the B6 mice. We propose that the
high virus load continuously activates naive B cells, maintaining
the serum Ab levels by IgG secretion by short-lived PCs. In the
CD4 T cell-deficient I-Ab/ mice, the virus load may not be
sufficiently high to ensure continuous B cell activation and sus-
tained IgG responses. This scenario is supported by our data
showing that transfer of CD8 T cells into T cell-deficient mice
decreases virus load and that it is also associated with a reduction
of antiviral IgG responses with time, similar to what was seen in
I-Ab/mice.
TCR KO or TCR KO mice had high virus load in bone
marrow, where B cells develop (Fig. 4C). This finding raises the
question of how can B cells that develop in the presence of PyV Ag
maintain their reactivity and not become tolerized to PyV? Most
viral infections activate innate immune responses and induce
multiple inflammatory signals, which may be important for the
early control of the pathogens, but they also shape the adaptive
immune responses. We have found previously that PyV infection
activates MyD88-mediated pathways, and these pathways play a
crucial role in themaintenance of long-term IgG responses to PyV
infection in immunocompetent (T cell-sufficient) mice (22).
MyD88 mediates signaling from most TLRs (except TLR3) and
the cytokine receptors IL-1R (interleukin-1 receptor) and IL-18R.
For the induction of long-lasting IgG responses to PyV, the cyto-
kine receptors were dispensable. These experiments show that
PyV as an Ag can simultaneously engage the B cell receptors and
TLRs. Remarkably, in transgenic B cell models, the presence of an
Ag with this “dual engagement capacity” was shown to lead to a
breach of anergy. Self-Ags that could bind the B cell receptor and
engage TLR7 or TLR9 generated autoantibodies (26). In bone
marrow, PyV can engage the BCR and be endocytosed by B cells
and then may be recognized by endosomal TLR7/TLR9-MyD88
mediated pathways.We speculate that the ability of PyV to initiate
signaling by both the BCR and the endosomal TLRs could be a key
step in allowing continuous PyV-specificAbproduction. In agree-
ment with this hypothesis, we found that the mice that were defi-
cient in both T cells and MyD88 signaling had diminished IgG
responses to PyV, in contrast to the long-lasting high-titer TI se-
rum IgG inMyD88-sufficient T cell-deficientmice. Therefore, the
continuous activation of naive B cells emerging from bone mar-
row by the high virus load may be successful only if innate im-
mune pathways are also activated by the Ag. This hypothetical
mechanismwould allow the newly differentiatedB cells to develop
anergy to harmless Ags they encounter in bone marrow, but Ags
sensed by innate immunity would still trigger Ab secretion.
We have reported previously that long-term humoral immu-
nity to PyV was defective in mice that lacked MyD88 even in the
presence of T cells, as the MyD88 KOmice failed to form LL PCs.
The results of this current study taken together with the previous
findings suggest that important mechanisms may ensure that
long-livedAb responses, both TI andTD, are generated andmain-
tained only to those Ags that activate innate immunity by their
pathogen-associated molecular patterns. This safeguard would
ensure protective humoral immunity against a viral pathogen
even under the conditions of partial immunodeficiency (lack of T
cells) but would greatly reduce the long-term production of irrel-
evant or autoreactive Abs and the occurrence of pathogenic
autoantibody-induced conditions.
MATERIALS AND METHODS
Mice and infection. All the mice used in the studies were on the C57BL/6
(B6) background. TCRKO,TCRKO,TCRKO, and SCIDmicewere
originally obtained from the Jackson Laboratory (Bar Harbor, ME), and
colonies of these mice were maintained in the Department of Animal
Medicine of the University of Massachusetts Medical School under
specific-pathogen-free conditions. TCR KO/MyD88/ mice were
bred by crossing TCR KO mice and MyD88 KO mice, and the mice
weremaintained at the animal facilities at the University ofMassachusetts
Medical School. Mice were used when they were between 8 and 12 weeks
of age, virus infections were done intranasally (i.n.) or intraperitoneally
(i.p.) with ~106 PFU/ mouse of PyV strain A2. All the procedures using
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animals were done according to protocols approved by the University of
Massachusetts Medical School Animal Care and Use Committee.
VP1-specific ELISA.VP1-specific enzyme-linked immunosorbent as-
says (ELISAs) were conducted as previously described (27). Briefly, puri-
fied recombinant VP1 protein was used to coat the wells of 96-well plates
(using 50 ng/well). Bound Ab was detected using biotin-conjugated goat
Abs specific for mouse IgG and streptavidin-conjugated horseradish per-
oxidase (HRP) (Vector Laboratories). ELISA plates were developed using
BD OptEIA 3,3=,5,5=-tetramethylbenzidine (TMB) substrate set (BD
Pharmingen), and the reactions were stopped with 2 N sulfuric acid. Op-
tical densities were read at 450 nm by THERMOMAX microplate reader
and SoftMax software. Data are represented as optical density versus se-
rum dilution (raw data) or are shown as IgG concentration expressed in
arbitrary units, which were calculated using a reference positive serum
dilution curve. IgG endpoint titers are defined as the highest serum dilu-
tions showing optical density in the ELISA above the values of negative-
control serum (mean standard deviation [SD]).
VP1-specific ELISPOT assay. To determine the number of VP1-
specific Ab-secreting cells (ASCs), multiscreen HTS filter plates (Milli-
pore) were coated with purified VP1 protein (0.1 g/ml in carbonate
buffer, 50 l/well). Wells coated with unlabeled goat anti-mouse
Ig(HL) (Southern Biotech) were used for determining total IgG ACSs,
and somewells were coatedwith carbonate buffer only (no-coat controls).
The plates were incubated overnight at 4°C and then blocked for 30min at
37°C with RPMI 1640 plus 10% fetal bovine serum (FBS). The cells were
plated in duplicate wells in 0.2 ml in each well at a concentration of
107 cells/ml, followed by 2-fold dilutions. The plates with cells were incu-
bated for 4 h at 37°C, then the cells were discarded, and the plates were
washed and blocked with 1% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS) for 30 min at 37°C. Bound Ab was detected using
biotinylated goat Abs specific for mouse IgG and streptavidin-conjugated
HRP. The spots were developed with ELISPOT 3-amino-9-ethyl-
carbazole (AEC) substrate set (BD Pharmingen) according to the manu-
facturer’s protocol and counted using the CTL ImmunoSpot (Cellular
Technology Ltd.).
qPCR to measure viral DNA genome copy number. DNA was pre-
pared from organ homogenates and used for quantitative PCR (qPCR)
assays to measure PyV copy numbers, as described previously (4).
Flow cytometry. Flow cytometry was performed as described previ-
ously (22). Abs used in these studies included fluorescein isothiocyanate
(FITC)-labeled rat anti-mouse T andB cell-activatingAgGL7 (cloneGL7;
BD Pharmingen), phycoerythrin and Cy7 (PECy7)-labeled rat anti-
mouse CD19 (clone 1D3; BD Pharmingen), PE-labeled hamster anti-
mouse CD95 (BDPharmingen), Pacific Blue-labeled rat anti-mouse B220
(clone RA3-6B2; BD Pharmingen). At least 100,000 events were counted
using an LSRII (BD Biosciences) and analyzed using FlowJo software
(Tree Star).
B cell memory assay.When the mice were between 8 and 12 weeks of
age, they were infected intraperitoneally with ~106 PFU/mouse of PyV
strain A2. Spleens were harvested from uninfected or PyV-infected (for 3
to 4 months) TCR KO, TCR KO, TCR KO, and B6 mice, and 107
spleen cells were transferred intravenously into uninfected SCID mice.
One day after the cell transfer, some of the SCIDmice of each group were
infected with PyV (~106 PFU/mouse i.p.), others were left uninfected.
Five to 7 days postinfection, recall PyV-specific responses from the sera of
SCID mice were measured by ELISA.
Transfer of CD8 T cells into T cell-deficient mice. Spleen cells har-
vested from Ly5.1 B6 mice were pooled and treated with 0.84%NH4Cl to
lyse red blood cells (RBC) and then resuspended in magnetic cell separa-
tion (MACS) buffer as instructed by themanufacturer’s protocols (Milte-
nyi Biotec MACS kit). CD8 T cell isolation kit (Miltenyi Biotec) for neg-
ative selection of CD8 T cells was used to purify CD8 T cells from the
wild-type splenocytes. Cell purity was checked by flow cytometry. Cells
were resuspended in Hanks balanced salt solution (HBSS) and intrave-
nously transferred into recipient mice. For CD8 T cell transfer experi-
ments, 7 106 wild-type CD8 T cells were intravenously (i.v.) transferred
into each of 5 TCR KO mice.
Statistical methods. For statistical comparisons, unpaired Student’s
t test was used, and data with P  0.05 were considered statistically sig-
nificant.
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